Skip to main content

. 1967 Nov;31(3):435–446. doi: 10.1111/j.1476-5381.1967.tb00410.x

The antihypertensive properties of 1-amino-4-phenyl pyridinium chloride.

V A Cullum, J B Farmer, S L Handley

PMCID: PMC1557331 PMID: 4295635

436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BARTLET A. L. Some cocaine-like actions of 3-phenoxypro-pylguanidine. Br J Pharmacol Chemother. 1962 Jun;18:475–489. doi: 10.1111/j.1476-5381.1962.tb01169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
BERTLER A., CARLSSON A., ROSENGREN E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol Scand. 1958 Dec 15;44(3-4):273–292. doi: 10.1111/j.1748-1716.1958.tb01627.x. [DOI] [PubMed] [Google Scholar]
BIRMINGHAM A. T., WILSON A. B. AN ANALYSIS OF THE BLOCKING ACTION OF DIMETHYLPHENYLPIPERAZINIUM IODINE ON THE INHIBITION OF ISOLATED SMALL INTESTINE PRODUCED BY STIMULATION OF SYMPATHETIC NERVES. Br J Pharmacol Chemother. 1965 Apr;24:375–386. doi: 10.1111/j.1476-5381.1965.tb01725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Brittain R. T., Farmer J. B., Jack D., Martin L. E., Ritchie A. C. 1-amino-4-phenyl pyridinium chloride: a potential antihypertensive agent. Nature. 1967 Feb 18;213(5077):731–732. doi: 10.1038/213731a0. [DOI] [PubMed] [Google Scholar]
CHEN G., ENSOR C. R., MCCARTHY D. A., MCLEAN J. R., CAMPBELL A. THE PHARMACOLOGY OF 3-PHENOXYPROPYLGUANIDINE. J Pharmacol Exp Ther. 1964 Mar;143:374–382. [PubMed] [Google Scholar]
DAY M. D., RAND M. J. Evidence for a competitive antagonism of guanethidine by dexamphetamine. Br J Pharmacol Chemother. 1963 Feb;20:17–28. doi: 10.1111/j.1476-5381.1963.tb01293.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
De la Lande I. S., Rand M. J. A simple isolated nerve-blood vessel preparation. Aust J Exp Biol Med Sci. 1965 Oct;43(5):639–656. doi: 10.1038/icb.1965.48. [DOI] [PubMed] [Google Scholar]
Farmer J. B. Liberation of noradrenaline from the dog spleen. J Pharm Pharmacol. 1966 Nov;18(11):765–767. doi: 10.1111/j.2042-7158.1966.tb07807.x. [DOI] [PubMed] [Google Scholar]
Finkleman B. On the nature of inhibition in the intestine. J Physiol. 1930 Sep 18;70(2):145–157. doi: 10.1113/jphysiol.1930.sp002683. [DOI] [PMC free article] [PubMed] [Google Scholar]
HUKOVIC S. Responses of the isolated sympathetic nerveductus deferens preparation of the guinea-pig. Br J Pharmacol Chemother. 1961 Apr;16:188–194. doi: 10.1111/j.1476-5381.1961.tb00312.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
MAXWELL R. A., PLUMMER A. J., SCHNEIDER F., POVALSKI H., DANIEL A. I. Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864). J Pharmacol Exp Ther. 1960 Jan;128:22–29. [PubMed] [Google Scholar]
MCEWEN L. M. The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain. J Physiol. 1956 Mar 28;131(3):678–689. doi: 10.1113/jphysiol.1956.sp005493. [DOI] [PMC free article] [PubMed] [Google Scholar]
ROGERS L. A., ATKINSON R. A., LONG J. P. RESPONSES OF ISOLATED PERFUSED ARTERIES TO CATECHOLAMINES AND NERVE STIMULATION. Am J Physiol. 1965 Aug;209:376–382. doi: 10.1152/ajplegacy.1965.209.2.376. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES